CONTEXT: Sex differences in lipid metabolism result in a less proatherogenic plasma lipid profile in premenopausal women than men. The mechanisms responsible for this are unclear but are thought to be related to differences in the sex hormone milieu in men and women. OBJECTIVE: Our objective was to evaluate the effect of endogenous sex hormones on very-low-density lipoprotein (VLDL) triglyceride (TG) and apolipoprotein B-100 (apoB-100) metabolism. EXPERIMENTAL DESIGN AND MAIN OUTCOME MEASURES: We measured basal VLDL-TG and VLDL-apoB-100 concentrations and kinetics by using stable isotope-labeled tracers. SETTING AND PARTICIPANTS: Eight premenopausal women [age, 43 + or - 8 yr; body mass index (BMI), 35 + or - 4 kg/m(2); mean + or - sd], eight postmenopausal women (age, 55 + or - 4 yr; BMI, 34 + or - 4 kg/m(2)), and eight men (age, 41 + or - 13 yr; BMI, 34 + or - 4 kg/m(2)) were studied at Washington University School of Medicine, St. Louis, MO. RESULTS: VLDL-TG secretion rate was approximately double (P < 0.05) in postmenopausal women and men compared with premenopausal women but not different in postmenopausal women and men. The secretion rate of VLDL-apoB-100 was not different in pre- and postmenopausal women but was greater (P < 0.05) in men than in women. CONCLUSIONS: Endogenous ovarian sex steroids are responsible for sexual dimorphism in VLDL-TG secretion, whereas VLDL-apoB-100 secretion is not regulated by female reproductive hormones.
CONTEXT: Sex differences in lipid metabolism result in a less proatherogenic plasma lipid profile in premenopausal women than men. The mechanisms responsible for this are unclear but are thought to be related to differences in the sex hormone milieu in men and women. OBJECTIVE: Our objective was to evaluate the effect of endogenous sex hormones on very-low-density lipoprotein (VLDL) triglyceride (TG) and apolipoprotein B-100 (apoB-100) metabolism. EXPERIMENTAL DESIGN AND MAIN OUTCOME MEASURES: We measured basal VLDL-TG and VLDL-apoB-100 concentrations and kinetics by using stable isotope-labeled tracers. SETTING AND PARTICIPANTS: Eight premenopausal women [age, 43 + or - 8 yr; body mass index (BMI), 35 + or - 4 kg/m(2); mean + or - sd], eight postmenopausal women (age, 55 + or - 4 yr; BMI, 34 + or - 4 kg/m(2)), and eight men (age, 41 + or - 13 yr; BMI, 34 + or - 4 kg/m(2)) were studied at Washington University School of Medicine, St. Louis, MO. RESULTS: VLDL-TG secretion rate was approximately double (P < 0.05) in postmenopausal women and men compared with premenopausal women but not different in postmenopausal women and men. The secretion rate of VLDL-apoB-100 was not different in pre- and postmenopausal women but was greater (P < 0.05) in men than in women. CONCLUSIONS: Endogenous ovarian sex steroids are responsible for sexual dimorphism in VLDL-TG secretion, whereas VLDL-apoB-100 secretion is not regulated by female reproductive hormones.
Authors: Manthos G Giannoulis; Nicola Jackson; Fariba Shojaee-Moradie; Peter H Sonksen; Finbarr C Martin; A Margot Umpleby Journal: Growth Horm IGF Res Date: 2006-10-09 Impact factor: 2.372
Authors: Johanna L Johnson; Cris A Slentz; Brian D Duscha; Gregory P Samsa; Jennifer S McCartney; Joseph A Houmard; William E Kraus Journal: Atherosclerosis Date: 2004-10 Impact factor: 5.162
Authors: Elisa Fabbrini; Faidon Magkos; B Selma Mohammed; Terri Pietka; Nada A Abumrad; Bruce W Patterson; Adewole Okunade; Samuel Klein Journal: Proc Natl Acad Sci U S A Date: 2009-08-24 Impact factor: 11.205
Authors: Melissa N Martinez; Christopher H Emfinger; Matthew Overton; Salisha Hill; Tara S Ramaswamy; David A Cappel; Ke Wu; Sergio Fazio; W Hayes McDonald; David L Hachey; David L Tabb; John M Stafford Journal: J Lipid Res Date: 2012-01-03 Impact factor: 5.922
Authors: María Concepción Robles Gil; R Timón; A F Toribio; D Muñoz; J I Maynar; M J Caballero; M Maynar Journal: Eur J Appl Physiol Date: 2011-05-11 Impact factor: 3.078
Authors: Xuewen Wang; Gordon I Smith; Bruce W Patterson; Dominic N Reeds; Janine Kampelman; Faidon Magkos; Bettina Mittendorfer Journal: Am J Physiol Endocrinol Metab Date: 2012-01-17 Impact factor: 4.310
Authors: Giada Ostinelli; Sofia Laforest; Scott G Denham; Marie-Frederique Gauthier; Virginie Drolet-Labelle; Emma Scott; Frédéric-Simon Hould; Simon Marceau; Natalie Z M Homer; Catherine Bégin; Ruth Andrew; André Tchernof Journal: J Clin Endocrinol Metab Date: 2022-07-14 Impact factor: 6.134